Press Release - Vetter Pharma

Vetter Pharma International GmbH · Postfach 23 80 · 88193 Ravensburg
Press Release
Vetter launches Project Management Quality Assurance Program
Employees to receive IPMA certification
Ravensburg, April 7, 2009 – With a new state-of-the-art project management program, Vetter will
help pharmaceutical and biotech companies to better control the quality and costs of their prefilled
injectable product manufacturing processes. As a specialist in the aseptic filling of syringes,
cartridges and vials, Vetter has launched an extensive quality assurance program for its project
managers, which ultimately should lead to their certification by the International Project
Management Association (IPMA).
Vetter expects the program to further boost its efficiency. In today’s competitive international
markets, pharmaceutical and biotechnology companies receive a boost from smooth processes
and short throughput times, which help get products to market more quickly.
“Before commercial manufacturing ever begins, we spend years working together with the
customer on packaging and production processes,” said Jochen Alberstetter, Vice President of
Project Management for Vetter. First, the basic tools of project management were introduced in
the entire company. “By undergoing an IPMA audit, we can now help our clients benefit from the
highest-quality project management available.”
The IPMA has set up a rigorous process to test project managers and ensure they are prepared
for the tasks that lie ahead. Each participant in the certification program must have at least three
years of experience in project management, plus two years of practical work leading a project.
The candidate is assessed on a wide variety of criteria, including the ability to plan, control,
communicate and solve problems. Certification then is awarded to those who demonstrate deep
organizational knowledge, as well as leadership qualities.
IPMA is a world leading project management organization that currently represents 45 national
project management associations and over 55,000 members on the international level. The IPMA
has a strong presence in Europe as well as North and South America, Asia and Africa. Because of
the proximity to Austria, the IPMA certification was carried out by Project Management Austria
(PMA).
For more information contact
Vetter Pharma International GmbH
Oskar Gold
Eywiesenstrasse 5
88212 Ravensburg
Germany
phone: +49-(0)751-3700 - 0
fax: +49-(0)751-3700 - 40 00
e-mail: info@vetter-pharma.com
www.vetter-pharma.com

About Vetter:
Vetter is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based
in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject®
dual-chamber syringe. The company employs about 1,900 people world-wide and holds nearly 140 patents.
Vetter boasts longstanding experience in handling client products and processes approved by the FDA, the
EMEA and other authorities.
Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages
of development, from clinical phases and regulatory approval to worldwide product launch. Vetter
Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to
the final packaging of a product. Vetter Solutions’ patented application systems enable clients to compete
more effectively throughout the world.